Method reducing TNF-alpha in mammals with cerebral malaria
US5624913A · kind A · utility
8Cited by
7References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 30, 1994 |
| Grant date | Apr 29, 1997 |
| Priority date | — |
| Expiry date | Aug 30, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A method for reducing the TNF-alpha in mammals with cerebral malaria comprising the administration of 2-methylthio-ATP or 2-chloro-ATP.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.